Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for INMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 629.13M
March 31, 2026 661.25M
December 31, 2025 683.20M
September 30, 2025 653.38M
June 30, 2025 628.44M
March 31, 2025 619.43M
December 31, 2024 703.81M
September 30, 2024 736.89M
June 30, 2024 751.12M
March 31, 2024 815.44M
December 31, 2023 787.37M
September 30, 2023 723.50M
June 30, 2023 666.16M
March 31, 2023 602.98M
December 31, 2022 554.62M
Date Value
September 30, 2022 508.30M
June 30, 2022 452.81M
March 31, 2022 403.32M
December 31, 2021 415.80M
September 30, 2021 384.03M
June 30, 2021 331.18M
March 31, 2021 293.75M
December 31, 2020 253.96M
September 30, 2020 232.03M
June 30, 2020 205.16M
March 31, 2020 194.83M
December 31, 2019 176.07M
September 30, 2019 160.44M
June 30, 2019 71.61M
March 31, 2019 53.88M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Xylo Technologies Ltd. --
Brainsway Ltd. 79.19M
IceCure Medical Ltd. 11.90M
IR-Med, Inc. -0.625M
QTREX Quantum Ltd. --

Shareholders Equity (Quarterly) Related Metrics